Buy 5-Amino-1MQ Canada | NNMT Inhibitor
Janoshik
Batch 51Q-CA-26A-01
Buy 5-Amino-1MQ Canada | NNMT Inhibitor
Nicotinamide N-Methyltransferase (NNMT) Inhibitor Research Compound
5-Amino-1MQ is a small-molecule compound commonly studied in laboratory research for its interaction with enzymes involved in cellular metabolism. Researchers examine its role in pathways related to NAD⁺ regulation and energy utilization at the cellular level. It is frequently used in biochemical and metabolic pathway studies.
This product is intended strictly for laboratory research use within Canada. It is not approved by Health Canada for the diagnosis, treatment, cure, or prevention of any disease. Not for human or veterinary use.
By purchasing, you confirm the material will be used solely for lawful research purposes in accordance with applicable Canadian regulations.
5-Amino-1MQ is a small-molecule research compound studied as an inhibitor of nicotinamide N-methyltransferase (NNMT), an enzyme involved in cellular metabolic regulation. It is developed for controlled laboratory investigation within experimental environments.
In scientific literature, 5-Amino-1MQ is examined in models evaluating NNMT-associated metabolic pathways, methylation-related signaling systems, and intracellular regulatory mechanisms under in vitro and preclinical research conditions.
Third-party tested for purity, identity, quantity.
5-Amino-1MQ is evaluated in research focused on NNMT pathway modulation and metabolic signaling systems. Experimental studies examine its interaction with enzymatic regulatory frameworks and intracellular methylation-associated processes within controlled laboratory environments.
Research publications have explored its biochemical interaction profile and pathway-level signaling characteristics under structured experimental conditions.
Research into NNMT as a metabolic regulatory enzyme led to the development of small-molecule inhibitors such as 5-Amino-1MQ. Investigations into enzymatic pathway modulation expanded into laboratory models evaluating metabolic regulation and intracellular signaling systems.
Subsequent studies documented its interaction with NNMT-related pathways in controlled experimental frameworks.
Laboratory investigations into 5-Amino-1MQ have focused on NNMT inhibition models and metabolic pathway regulation systems. Research frameworks evaluate enzymatic interaction dynamics, methylation-associated processes, and intracellular regulatory mechanisms under controlled in vitro and preclinical conditions.
0 of the 4 areas below are addressed directly by a paper cited on this page.
NNMT inhibition models
No paper cited on this page reports on nnmt or inhibition. This heading marks where 5-Amino-1MQ is discussed in the category rather than a question the cited literature answers, and it is worth knowing which of these areas has work behind it and which does not.
Metabolic pathway regulation studies
No paper cited on this page reports on metabolic or regulation. This heading marks where 5-Amino-1MQ is discussed in the category rather than a question the cited literature answers, and it is worth knowing which of these areas has work behind it and which does not.
Enzymatic signaling framework investigations
No paper cited on this page reports on enzymatic. This heading marks where 5-Amino-1MQ is discussed in the category rather than a question the cited literature answers, and it is worth knowing which of these areas has work behind it and which does not.
Intracellular methylation pathway research
No paper cited on this page reports on intracellular or methylation. This heading marks where 5-Amino-1MQ is discussed in the category rather than a question the cited literature answers, and it is worth knowing which of these areas has work behind it and which does not.
The references section of this page cites 2 primary papers published between 2017 and 2024 — a thin record. Every citation is linked to its PubMed or DOI record so it can be read rather than taken on trust, and the summaries above describe what those papers report rather than what the compound is claimed to do.
5-Amino-1MQ is frequently listed as a peptide by suppliers in this market. It is not one. The structure published on this page is the compound's actual chemistry, and research on it should be read against its own class rather than against peptide literature.
Research compounds attract claims that outrun their evidence. Below are the ones most often encountered for 5-Amino-1MQ, set against what the papers cited on this page actually report. Where the record is thin or contested, that is stated rather than smoothed over.
5-Amino-1MQ is also referred to as 5A1MQ, 5 amino.
5-Amino-1MQ is commonly described online in connection with weight loss, appetite suppression and fat reduction. In the research literature the same compound is filed under NNMT inhibition models, metabolic pathway regulation studies and enzymatic signaling framework investigations.
The 2 papers cited on this page, published between 2017 and 2024 describe laboratory and animal work. None reports a controlled trial in humans. Findings in cell culture or in a rodent model describe what happened in that system; they do not establish that the same occurs in humans, and this compound is not approved for human use.
Presented alongside compounds with decades of published research, as though the evidence base is comparable.
It is not. 5-Amino-1MQ rests on 2 cited papers (between 2017 and 2024). A record that thin cannot support conclusions about mechanism, effect or safety, and the honest reading is that this compound has been studied very little rather than studied and validated.
Nothing above is a statement of what this material does. It is a summary of what has been published and what has not. Eppix Labs supplies research materials only and provides no dosing, administration or protocol guidance.
Verification for 5-Amino-1MQ is per lot, not per product. The current 10mg lot 51Q-CA-26A-01 returned 99.55% purity, 11.17 mg measured, 111.7% of the labelled 10 mg, assayed by Janoshik. Those figures are the laboratory's, published in full rather than reduced to a badge.
Purity is half the number. It states what fraction of the material in the vial is 5-Amino-1MQ; it says nothing about how much material is in the vial, and a short-filled vial can return a purity result that is entirely accurate. The figure that answers the second question is measured mass against expected content — for 5-Amino-1MQ, this lot measured 111.7% of its labelled 10 mg. Both numbers are published for every lot, whichever way they fall.
The lot code printed on the vial matches the code on the certificate for 5-Amino-1MQ. Matching the two is what confirms the unit in hand came from the batch that was tested — a certificate not tied to a lot code proves nothing about any particular unit.
Researchers who buy 5-Amino-1MQ in Canada through Eppix Labs receive the lot described by the certificate above: the code printed on the vial label is the code on the certificate, and both are searchable on the batch verification page.
- Lyophilized storage
- −20 °C long-term; stable at room temperature in transit
- After reconstitution
- 2–8 °C
- Light
- Protect from UV and direct light
- Freeze-thaw
- Avoid repeated cycles
- Vehicle
- Solvent selection depends on the compound; consult the published literature
- Format
- Lyophilized powder
5-Amino-1MQ is supplied as lyophilized powder. It is not a peptide, and solvent behaviour follows from its own chemistry rather than from the aqueous-vehicle conventions that apply to peptide material — the published literature for this compound is the reference for solvent selection, not a general peptide protocol.
Dry storage below freezing and protection from light are the general controls. As with any lyophilized material, the powder frequently sits as a thin film at the base of the vial and is easy to mistake for an empty vial before inspection.
Vials may appear empty on arrival. Lyophilized material collects at the base of the vial and is often not visible until the vial is inspected under direct light.
- 1 × sealed glass vial in the strength selected (10mg / Single Vial, 10mg / 5-Pack, 10mg / 10-Pack available), batch-labelled
- The batch-linked Certificate of Analysis for the exact lot shipped
- Discreet outer packaging with no product names on the exterior
- Canada Post Xpress, tracked, typically 1–2 business days from Alberta
- Bacteriostatic water or any other reconstitution vehicle
- Syringes, needles or filters
- Dosing, administration or protocol guidance of any kind
Reconstitution materials are sourced separately. The reconstitution calculator on this site works out concentrations for a given volume, but it is an arithmetic tool for laboratory record-keeping and not a protocol.
No. Eppix Labs products are supplied exclusively for laboratory research. We do not provide dosing, administration, or usage guidance.
Each vial contains 10mg of 5-Amino-1MQ. Independent third-party testing verifies purity, identity, and net content per batch.
The vial contains only the compound. Any laboratory materials required for experimental procedures must be sourced separately.
Duration depends entirely on research protocol, storage conditions, and laboratory application.
Related
You May Also Like
Next-generation GLP receptor agonist studied for metabolic signaling and nutrient partitioning pathways
$60.00
$70.00
Dual incretin receptor agonist studied for glucose regulation, metabolic signaling, and weight pathway research
$35.00
$40.00
Studied in metabolic research for its effects on glucose regulation, appetite signaling, and energy balance.
From$70.00
This product is supplied as eloralintide (LY3841136), a long-acting, selective amylin receptor agonist studied in research on metabolic and body-weight regulation.
$150.00